Iovance Biotherapeutics, Inc. (IOVA) — SC 13D/A Filings
All SC 13D/A filings from Iovance Biotherapeutics, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Rothbaum Amends Iovance Stake Filing
— Mar 19, 2024 Risk: medium
Wayne P. Rothbaum, through Quogue Capital LLC, has amended their Schedule 13D filing regarding Iovance Biotherapeutics, Inc. on March 19, 2024. The filing indic
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX